Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWJ1276 in Hypertension and Dyslipidemia
NCT01764295Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Sep 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan medoxomil + amlodipine in hypertension (HTN), dyslipidemia, sponsored by Daewoong Pharmaceutical. Started Sep 2012; status: completed.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT01764295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764295.